This research identified 12 ingredients of FRP treatment of AD by targeting 235 targets via multiple pathways, which were concentrated on the neuroactive ligand-receptor interaction, PI3K-Akt, calcium signaling, and cAMP signaling pathways. This evidence concerns the gene PIK3CD and Alzheimer disease.